US Stock MarketDetailed Quotes

SLXN Silexion Therapeutics

Watchlist
  • 0.285
  • -0.035-10.94%
Close Nov 27 16:00 ET
  • 0.286
  • +0.001+0.35%
Post 18:24 ET
4.11MMarket Cap-140P/E (TTM)

Silexion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-287.30%-2.65M
36.46%-1.07M
-92.32%-1.75M
-35.80%-4.53M
-1.26M
-685K
-1.68M
-911K
-3.34M
Net income from continuing operations
-1,366.01%-11.86M
20.63%-1.49M
-91.52%-1.42M
-46.44%-5.11M
---1.68M
---809K
---1.88M
---743K
---3.49M
Operating gains losses
----
----
----
---1K
--0
---1K
----
----
----
Depreciation and amortization
120.00%22K
-50.00%7K
-46.67%8K
-21.05%45K
--6K
--10K
--14K
--15K
--57K
Other non cash items
3,434.26%3.82M
-70.14%83K
747.62%136K
218.66%318K
---47K
--108K
--278K
---21K
---268K
Change In working capital
-1,620.00%-430K
343.55%302K
-160.31%-505K
-63.60%87K
--430K
---25K
---124K
---194K
--239K
-Change in receivables
-170.83%-17K
110.00%2K
-500.00%-44K
145.00%18K
--3K
--24K
---20K
--11K
---40K
-Change in prepaid assets
-110.61%-417K
-1,360.00%-63K
-1,742.86%-129K
-179.28%-329K
---129K
---198K
--5K
---7K
--415K
-Change in payables and accrued expense
-336.59%-388K
518.39%364K
-149.02%-381K
993.88%438K
--514K
--164K
---87K
---153K
---49K
-Change in other working capital
2,713.33%392K
95.45%-1K
208.89%49K
54.02%-40K
--42K
---15K
---22K
---45K
---87K
Cash from discontinued investing activities
Operating cash flow
-287.30%-2.65M
36.46%-1.07M
-92.32%-1.75M
-35.80%-4.53M
---1.26M
---685K
---1.68M
---911K
---3.34M
Investing cash flow
Cash flow from continuing investing activities
-122.22%-16K
0
-101.18%-6K
209.35%573K
-4K
72K
-2K
507K
-524K
Net PPE purchase and sale
-122.22%-16K
--0
---6K
265.00%66K
---4K
--72K
---2K
--0
---40K
Net investment purchase and sale
--0
--0
--0
204.75%507K
--0
--0
--0
--507K
---484K
Cash from discontinued investing activities
Investing cash flow
-122.22%-16K
--0
-101.18%-6K
209.35%573K
---4K
--72K
---2K
--507K
---524K
Financing cash flow
Cash flow from continuing financing activities
2.92M
0
-81.03%522K
0
0
522K
0
2.75M
Net common stock issuance
--620K
----
----
----
----
--0
----
----
----
Net preferred stock issuance
--0
--0
----
-81.01%522K
--0
--0
--522K
----
--2.75M
Proceeds from stock option exercised by employees
----
--0
----
--0
----
----
--0
--0
--3K
Net other financing activities
--2.3M
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--2.92M
--0
--0
-81.03%522K
--0
--0
--522K
--0
--2.75M
Net cash flow
Beginning cash position
-73.09%1.75M
-64.27%2.83M
-44.10%4.65M
-17.59%8.31M
--5.81M
--6.49M
--7.92M
--8.31M
--10.08M
Current changes in cash
140.95%251K
7.87%-1.07M
-335.15%-1.76M
-210.21%-3.43M
---1.26M
---613K
---1.16M
---404K
---1.11M
Effect of exchange rate changes
137.88%25K
93.14%-19K
-394.74%-56K
65.52%-230K
--94K
---66K
---277K
--19K
---667K
End cash Position
-65.19%2.02M
-73.09%1.75M
-64.27%2.83M
-44.10%4.65M
--4.65M
--5.81M
--6.49M
--7.92M
--8.31M
Free cash flow
-286.25%-2.67M
36.53%-1.07M
-92.97%-1.76M
-34.55%-4.54M
---1.26M
---691K
---1.68M
---911K
---3.38M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -287.30%-2.65M36.46%-1.07M-92.32%-1.75M-35.80%-4.53M-1.26M-685K-1.68M-911K-3.34M
Net income from continuing operations -1,366.01%-11.86M20.63%-1.49M-91.52%-1.42M-46.44%-5.11M---1.68M---809K---1.88M---743K---3.49M
Operating gains losses ---------------1K--0---1K------------
Depreciation and amortization 120.00%22K-50.00%7K-46.67%8K-21.05%45K--6K--10K--14K--15K--57K
Other non cash items 3,434.26%3.82M-70.14%83K747.62%136K218.66%318K---47K--108K--278K---21K---268K
Change In working capital -1,620.00%-430K343.55%302K-160.31%-505K-63.60%87K--430K---25K---124K---194K--239K
-Change in receivables -170.83%-17K110.00%2K-500.00%-44K145.00%18K--3K--24K---20K--11K---40K
-Change in prepaid assets -110.61%-417K-1,360.00%-63K-1,742.86%-129K-179.28%-329K---129K---198K--5K---7K--415K
-Change in payables and accrued expense -336.59%-388K518.39%364K-149.02%-381K993.88%438K--514K--164K---87K---153K---49K
-Change in other working capital 2,713.33%392K95.45%-1K208.89%49K54.02%-40K--42K---15K---22K---45K---87K
Cash from discontinued investing activities
Operating cash flow -287.30%-2.65M36.46%-1.07M-92.32%-1.75M-35.80%-4.53M---1.26M---685K---1.68M---911K---3.34M
Investing cash flow
Cash flow from continuing investing activities -122.22%-16K0-101.18%-6K209.35%573K-4K72K-2K507K-524K
Net PPE purchase and sale -122.22%-16K--0---6K265.00%66K---4K--72K---2K--0---40K
Net investment purchase and sale --0--0--0204.75%507K--0--0--0--507K---484K
Cash from discontinued investing activities
Investing cash flow -122.22%-16K--0-101.18%-6K209.35%573K---4K--72K---2K--507K---524K
Financing cash flow
Cash flow from continuing financing activities 2.92M0-81.03%522K00522K02.75M
Net common stock issuance --620K------------------0------------
Net preferred stock issuance --0--0-----81.01%522K--0--0--522K------2.75M
Proceeds from stock option exercised by employees ------0------0----------0--0--3K
Net other financing activities --2.3M--------------------------------
Cash from discontinued financing activities
Financing cash flow --2.92M--0--0-81.03%522K--0--0--522K--0--2.75M
Net cash flow
Beginning cash position -73.09%1.75M-64.27%2.83M-44.10%4.65M-17.59%8.31M--5.81M--6.49M--7.92M--8.31M--10.08M
Current changes in cash 140.95%251K7.87%-1.07M-335.15%-1.76M-210.21%-3.43M---1.26M---613K---1.16M---404K---1.11M
Effect of exchange rate changes 137.88%25K93.14%-19K-394.74%-56K65.52%-230K--94K---66K---277K--19K---667K
End cash Position -65.19%2.02M-73.09%1.75M-64.27%2.83M-44.10%4.65M--4.65M--5.81M--6.49M--7.92M--8.31M
Free cash flow -286.25%-2.67M36.53%-1.07M-92.97%-1.76M-34.55%-4.54M---1.26M---691K---1.68M---911K---3.38M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data